speb/financial-data huggingface dataset:
CHR.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 289423000.00
CHR.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -17459000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Minority Interest: 0.00
CHR.TO income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
CHR.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -14354000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 313935000.00
CHR.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -12257000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Net Income: 32437000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 32437000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 32437000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 0.00
CHR.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 32437000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 32437000.00
CHR.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 32437000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 32437000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -3509000.00
CHR.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -17459000.00
CHR.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -17459000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -3509000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 968548000.00
CHR.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -6871000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 528394000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 5831000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 188769000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 188769000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 52167000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 20314240.00
CHR.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 22829000.00
CHR.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -12266000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Operating Income: 24072000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 294200000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 25850965.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 91997000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 25429000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 12270000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1681000.00
CHR.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 159000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 41756000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 50665000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 41461000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Other Receivables: 1004000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Payables: 192026000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 192026000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 451000.00
CHR.TO cash_flow (quarterly, 2025-06-30) — Preferred Stock Dividend Paid: 0.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 20672000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 32833000.00
CHR.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -7126000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 99047000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 259079000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 27257000.00
CHR.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -17459000.00
CHR.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -14354000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -787135000.00
CHR.TO cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 255000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 25850965.00
CHR.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: 9000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 537225000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 528394000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 147240.00
CHR.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 396000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.01
CHR.TO balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 8825000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 1353413000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 815253000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 384277000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 537225000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 300540000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 816188000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1024966000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 528857000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 24072000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 520000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 12270000.00
CHR.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 12270000.00
CHR.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 41116000.00
CHR.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 14038811.00
CHR.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 25477236.00
CHR.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 25477236.00
CHR.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -1840189.00
CHR.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.35
CHR.TO income_statement (annual, 2025-12-31) — +Operating Expense: 165258000.00
CHR.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 40329000.00
CHR.TO income_statement (annual, 2025-12-31) — +Total Revenue: 1316498000.00
CHR.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 320190000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 170404000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 170404000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 108563000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 108563000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -813012000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -813012000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 897900000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 897900000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -315000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -315000.00
CHR.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 25790838.00
CHR.TO income_statement (annual, 2025-12-31) — Basic EPS: 3.05
CHR.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 222216000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 26537000.00
CHR.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -34892000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -8939000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 13675000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 13675000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 344043000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 344043000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 28656000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 28656000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 28656000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 28656000.00
CHR.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -3931000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -1873000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Cash Financial: 28656000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 28656000.00
CHR.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -225487000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -20101000.00
CHR.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -28041000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -753000.00
CHR.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 62747000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 23213000.00
CHR.TO cash_flow (annual, 2025-12-31) — Cash From Discontinued Financing Activities: 0.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Financing Activities: 0.00
CHR.TO cash_flow (annual, 2025-12-31) — Cash From Discontinued Investing Activities: 0.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Investing Activities: 0.00
CHR.TO cash_flow (annual, 2025-12-31) — Cash From Discontinued Operating Activities: 0.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Operating Activities: 0.00
CHR.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: -135665000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -7306000.00
CHR.TO cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: -2610000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: -10000.00
CHR.TO cash_flow (annual, 2025-12-31) — Change In Inventory: 5246000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: 2420000.00
CHR.TO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 9062000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 5144000.00
CHR.TO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 2818000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -2530000.00
CHR.TO cash_flow (annual, 2025-12-31) — Change In Payable: -138275000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: -7316000.00
CHR.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -138275000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -7316000.00
CHR.TO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -3510000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -5505000.00
CHR.TO cash_flow (annual, 2025-12-31) — Change In Receivables: 21836000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -3052000.00
CHR.TO cash_flow (annual, 2025-12-31) — Change In Tax Payable: -2610000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: -10000.00
CHR.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -102823000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -10839000.00
CHR.TO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 23472000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -10253000.00
CHR.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -190781000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 2359000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Common Stock: 344043000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 344043000.00
CHR.TO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -3931000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -1873000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 507837000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 507837000.00
CHR.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -85800000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -50271000.00
CHR.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 1051635000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 258885000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 0.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 0.00
CHR.TO balance_sheet (annual, 2025-12-31) — Current Assets: 336751000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 336751000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 2553000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 2553000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Current Debt: 64336000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 64336000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 66889000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 66889000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 258818000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 258818000.00
CHR.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: -7538000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -3598000.00
CHR.TO cash_flow (annual, 2025-12-31) — Deferred Tax: -7538000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: -3598000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Defined Pension Benefit: 5749000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 5749000.00
CHR.TO cash_flow (annual, 2025-12-31) — Depreciation: 107278000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Depreciation: 26148000.00
CHR.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 107278000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 26148000.00
CHR.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 107278000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 26148000.00
CHR.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 26188745.00
CHR.TO income_statement (annual, 2025-12-31) — Diluted EPS: 3.01
CHR.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 78739000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 16703000.00
CHR.TO income_statement (annual, 2025-12-31) — EBIT: 116256000.00
CHR.TO income_statement (quarterly, 2025-12-31) — EBIT: 27073000.00
CHR.TO income_statement (annual, 2025-12-31) — EBITDA: 223534000.00
CHR.TO income_statement (quarterly, 2025-12-31) — EBITDA: 53221000.00
CHR.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -2779000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -240000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Employee Benefits: 48113000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 48113000.00
CHR.TO cash_flow (annual, 2025-12-31) — End Cash Position: 28656000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 28656000.00
CHR.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -225487000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -20101000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: 2530000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: 2530000.00
CHR.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 27855000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 14274000.00
CHR.TO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -18000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -8000.00
CHR.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 19000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 9000.00
CHR.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 12814000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 5614000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 2530000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 2530000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Goodwill: 10371000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 10371000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 12052000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 12052000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 108878000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 108878000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 1733125000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1733125000.00
CHR.TO income_statement (annual, 2025-12-31) — Gross Profit: 264863000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 61305000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 1211000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 1211000.00
CHR.TO cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 31691000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Income Tax Payable: 0.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 0.00
CHR.TO income_statement (annual, 2025-12-31) — Interest Expense: 17616000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 3868000.00
CHR.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 17616000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 3868000.00
CHR.TO income_statement (annual, 2025-12-31) — Interest Income: 3818000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Interest Income: 474000.00
CHR.TO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 3818000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 474000.00
CHR.TO cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 18074000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Inventory: 159204000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 159204000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 868318000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 868318000.00
CHR.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -28041000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -753000.00
CHR.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 50000000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Leases: 12076000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Leases: 12076000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 11122000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 11122000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 296145000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 296145000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 307267000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 307267000.00
CHR.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 50000000.00
CHR.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -185756000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -17957000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 49607000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 49607000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Minority Interest: 0.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Minority Interest: 0.00
CHR.TO income_statement (annual, 2025-12-31) — Minority Interests: 0.00
CHR.TO income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
CHR.TO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -2043000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 45000.00
CHR.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -85800000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -50271000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Net Debt: 331825000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 331825000.00
CHR.TO cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -12409000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -5281000.00
CHR.TO income_statement (annual, 2025-12-31) — Net Income: 78739000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Net Income: 16703000.00
CHR.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 78739000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 16703000.00
CHR.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 78739000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 16703000.00
CHR.TO income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 0.00
CHR.TO income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
CHR.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 78739000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 16703000.00
CHR.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 78739000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 16703000.00
CHR.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 78739000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 16703000.00
CHR.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 78739000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 16703000.00
CHR.TO income_statement (annual, 2025-12-31) — Net Interest Income: -13798000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -3394000.00
CHR.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -135756000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 32043000.00
CHR.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -135756000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 32043000.00
CHR.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -13798000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -3394000.00
CHR.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 998000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Net PPE: 920113000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 920113000.00
CHR.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -26996000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1796000.00
CHR.TO cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 0.00
CHR.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 495785000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 495785000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 35648000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 35648000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 187623000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 187623000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 187623000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 187623000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 10738000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 10738000.00
CHR.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 210701000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 47598000.00
CHR.TO income_statement (annual, 2025-12-31) — Normalized Income: 68498266.00
CHR.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 12655554.66
CHR.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 62747000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 23213000.00
CHR.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -12427000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -5289000.00
CHR.TO income_statement (annual, 2025-12-31) — Operating Income: 99605000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Operating Income: 20976000.00
CHR.TO income_statement (annual, 2025-12-31) — Operating Revenue: 1316498000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 320190000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 23415381.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 23415381.00
CHR.TO balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 64336000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 64336000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 2773000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 2773000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Other Equity Interest: 24366000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 24366000.00
CHR.TO income_statement (annual, 2025-12-31) — Other Income Expense: 12833000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 5623000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 1681000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 1681000.00
CHR.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: -482000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 88000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 133000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 133000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 788000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 788000.00
CHR.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: 165400000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 40471000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Other Payable: 645000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Other Payable: 645000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Other Properties: 112998000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 112998000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Other Receivables: 3874000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 3874000.00
CHR.TO income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
CHR.TO balance_sheet (annual, 2025-12-31) — Payables: 189156000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Payables: 189156000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 189156000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 189156000.00
CHR.TO cash_flow (annual, 2025-12-31) — Preferred Stock Dividend Paid: 0.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: 0.00
CHR.TO cash_flow (annual, 2025-12-31) — Preferred Stock Payments: 0.00
CHR.TO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 24723000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 24723000.00
CHR.TO income_statement (annual, 2025-12-31) — Pretax Income: 98640000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 23205000.00
CHR.TO income_statement (annual, 2025-12-31) — Provision For Doubtful Accounts: -142000.00
CHR.TO cash_flow (annual, 2025-12-31) — Purchase Of Business: -2043000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 45000.00
CHR.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -34892000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -8939000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Receivables: 122957000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 122957000.00
CHR.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1051635000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 258885000.00
CHR.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 107278000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 26148000.00
CHR.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -185756000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -17957000.00
CHR.TO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -85800000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -50271000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: -761002000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -761002000.00
CHR.TO cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
CHR.TO cash_flow (annual, 2025-12-31) — Sale Of PPE: 7896000.00
CHR.TO cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 7143000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Share Issued: 23415381.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 23415381.00
CHR.TO income_statement (annual, 2025-12-31) — Special Income Charges: 19000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: 9000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 507837000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 507837000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 495785000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 495785000.00
CHR.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 2592266.00
CHR.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 1575554.66
CHR.TO income_statement (annual, 2025-12-31) — Tax Provision: 19901000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 6502000.00
CHR.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.20
CHR.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.28
CHR.TO balance_sheet (annual, 2025-12-31) — Taxes Receivable: 10520000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 10520000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Total Assets: 1310446000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 1310446000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 803982000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 803982000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Total Debt: 374156000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 374156000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 507837000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 507837000.00
CHR.TO income_statement (annual, 2025-12-31) — Total Expenses: 1216893000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 299214000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 802609000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 802609000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 973695000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 973695000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 543791000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 543791000.00
CHR.TO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 99605000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 20976000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 18107000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 18107000.00
CHR.TO income_statement (annual, 2025-12-31) — Total Unusual Items: 12833000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 5623000.00
CHR.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 12833000.00
CHR.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 5623000.00
CHR.TO balance_sheet (annual, 2025-12-31) — Working Capital: 77933000.00
CHR.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 77933000.00
CHR.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 40874000.00
CHR.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 325424000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 197007000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 81957000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 893345000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 23371115.00
CHR.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.30
CHR.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 29180000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -11173000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 13200000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 335850000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 98032000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 98032000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -2564000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Cash Financial: 98032000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -3034000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 7058000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 63577000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -2841000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 0.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: -1325000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 2091000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -2876000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 5545000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Change In Payable: -2841000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -2841000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -2312000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 32504000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 0.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 30786000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 31039000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 67601000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 335850000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -2564000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 499192000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -5251000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 266396000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 373707000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 2502000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Current Debt: 65924000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 68426000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 270978000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -3706000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: -3706000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Depreciation: 25382000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 25382000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 25382000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 23852090.00
CHR.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.29
CHR.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 7001000.00
CHR.TO income_statement (quarterly, 2026-03-31) — EBIT: 14725000.00
CHR.TO income_statement (quarterly, 2026-03-31) — EBITDA: 40107000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 1251000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 98032000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -3034000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Foreign Currency Translation Adjustments: 2543000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 52404000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 0.00
CHR.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 0.00
CHR.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -3852000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 2543000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Goodwill: 10371000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 12052000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 59028000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 6198000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 3756000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 3756000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Interest Income: 423000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 423000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 3356000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 158395000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 869413000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 7058000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 20000000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 10698000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 304297000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 314995000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 20000000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -15219000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -5251000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Net Debt: 272189000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 3979000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Net Income: 7001000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 7001000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 7001000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 7001000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 7001000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 7001000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 7001000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -3333000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 4781000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 4781000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -3333000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 890926000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 7058000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 487140000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 5145000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 183787000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 183787000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 43959000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 9458576.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 63577000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 3979000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Operating Income: 18154000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 325424000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 23187296.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 65924000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 24366000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: -3852000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1681000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 135000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 33778000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 46656000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 40874000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 1075000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Payables: 197007000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 197007000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 5545000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 27035000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 10969000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -11173000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 90245000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 266396000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 25382000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -15219000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -5251000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -756912000.00
CHR.TO cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 18231000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 23187296.00
CHR.TO income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 499192000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 487140000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -1394424.00
CHR.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 3968000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.36
CHR.TO balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 7213000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 1315608000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 803489000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 383421000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 499192000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 307270000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 816416000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 941901000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 545438000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 18154000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: -3852000.00
CHR.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -3852000.00
CHR.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 102729000.00
CHRD balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 1029318000.00
CHRD cash_flow (annual, 2021-12-31) — Common Stock Issuance: 86467000.00
CHRD balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 105585000.00
CHRD balance_sheet (annual, 2021-12-31) — Current Deferred Revenue: 103693000.00
CHRD balance_sheet (annual, 2021-12-31) — Dueto Related Parties Current: 1892000.00
CHRD cash_flow (annual, 2021-12-31) — Earnings Losses From Equity Investments: 0.00
CHRD cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 0.00
CHRD cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: -222806000.00
CHRD income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 3000.00
CHRD cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 20000000.00
CHRD cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 86467000.00
CHRD balance_sheet (annual, 2021-12-31) — Liabilities Heldfor Sale Non Current: 0.00
CHRD balance_sheet (annual, 2021-12-31) — Minority Interest: 188673000.00
CHRD balance_sheet (annual, 2021-12-31) — Net Debt: 220410000.00
CHRD income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 130642000.00
CHRD cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -220889000.00
CHRD cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: 373155000.00
CHRD cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: -507000000.00
CHRD balance_sheet (annual, 2021-12-31) — Non Current Deferred Assets: 0.00
CHRD balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 0.00
CHRD balance_sheet (annual, 2021-12-31) — Other Inventories: 12175000.00
CHRD balance_sheet (annual, 2021-12-31) — Other Receivables: 28270000.00